NewsDesk @bactiman63 The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus™ (nirsevimab-alip) for the prevention of respiratory syncytial virus (RSV) lower respiratory...

NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia...

NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate...

NewsDesk @bactiman63 Nirsevimab is a long-acting antibody designed for all infants for protection against RSV disease from birth through their first RSV season with a single dose, is being developed jointly...

NewsDesk @bactiman63 Mpox patients treated with tecovirimat, an antiviral drug widely used since last summer’s outbreak, had similar outcomes regardless of HIV status, researchers at Columbia University’s...

NewsDesk @bactiman63 On Monday, the CDC reported an increasing threat of the emerging fungus Candida auris. Today, the U.S. FDA today approved Cidara Therapeutics and Melinta Therapeutics’ REZZAYOTM...

NewsDesk @bactiman63 Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise...

Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced...

Gilead Sciences, Inc. announced this week that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the...

NewsDesk @bactiman63 Genentech today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult...